Tomo, Tristhan C.

HRN: 28-58-52  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/16/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/16/2026
02/23/2026
IV
200mg
Q6
Cellulitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: